Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
9.31
-0.01 (-0.11%)
Aug 14, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.32 | Buy | Reiterates | $15.32 | +64.59% | Aug 12, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $26.47 | Buy | Reiterates | $26.47 | +184.28% | Aug 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $23.68 | Buy | Maintains | $23.68 | +154.36% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $34.82 | Buy | Reiterates | $34.82 | +274.06% | Aug 12, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 12, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.29 | Buy | Maintains | $22.29 | +139.40% | Aug 12, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.50 | Buy | Maintains | $19.50 | +109.47% | Aug 3, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $19.50 | Buy | Reiterates | $19.50 | +109.47% | May 5, 2026 |